Abstract
INTRODUCTION An earlier age of menopause (AOM) is hypothesized to increase vulnerability to the neuropathological processes of dementia which begin in midlife.
METHODS We tested this hypothesis in a sample of 10,832 women from the Swedish Twin Registry, stratified by menopause etiology. Survival models showed that a U-shaped association was present for women whose menopause occurred spontaneously. Sensitivity analyses conducted in hormone naïve, APOE ε4+ and AOM restricted subsamples showed largely analogous patterns of results.
DISCUSSION Supporting conclusions from basic research, our results suggest that estrogens (proxied here by AOM) interact with several biological pathways mediating dementia disease processes. In line with trends in hormone research across the past century, our findings challenge the oversimplified ’more-is-better’ perspective on hormone exposure. Specifically, the non-linear association we observed between AOM and dementia risk points to the involvement of distinct and interacting biological mechanisms beyond just estrogen levels.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by NIH grant numbers R21 AG074212 and R01 AG060470 and by the Swedish Research Council under the grant no 2017-00641
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB of University of California San Diego waived ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Data can be requested from the Karolinska Institutet; https://ki.se/en/research/research-infrastructure-and-environments/core-facilities-for-research/the-swedish-twin-registry
Abbreviations
- AOM
- Age of menopause
- CPHR
- Cox proportional hazards regression
- IM
- Induced menopause
- OC
- Oral contraceptives
- MCCC
- Multidisciplinary clinical consensus conference
- MHT
- Menopausal hormone therapy
- SM
- Spontaneous menopause
- STR
- Swedish Twin Registry
